Abstract:
BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II randomized clinical trial of 123 patients with Her2-negative breast cancer was conducted, with patients treated with neoadjuvant chemotherapy (fluorouracil (5FU)/epirubicin/cyclophosphamide (FEC) and taxane), with or without bevacizumab. Serial biopsies were obtained at time of diagnosis, after 12 weeks of treatment with FEC ± bevacizumab, and after 25 weeks of treatment with taxane ± bevacizumab. A time course study was designed to investigate the genomic landscape at the three time points when tumor DNA alterations, tumor percentage, genomic instability, and tumor clonality were assessed. Substantial differences were observed with some tumors changing mainly between diagnosis and at 12 weeks, others between 12 and 25 weeks, and still others changing in both time periods. RESULTS:In both treatment arms, good responders (GR) and non-responders (NR) displayed significant difference in genomic instability index (GII) at time of diagnosis. In the combination arm, copy number alterations at 25 loci at the time of diagnosis were significantly different between the GR and NR. An inverse aberration pattern was also observed between the two extreme response groups at 6p22-p12 for patients in the combination arm. Signs of subclonal reduction were observed, with some aberrations disappearing and others being retained during treatment. Increase in subclonal amplification was observed at 6p21.1, a locus which contains the VEGFA gene for the protein which are targeted by the study drug bevacizumab. Of the 13 pre-treatment samples that had a gain at VEGFA, 12 were responders. Significant decrease of frequency of subclones carrying gains at 17q21.32-q22 was observed at 12 weeks, with the peak occurring at TMEM100, an ALK1 receptor signaling-dependent gene essential for vasculogenesis. This implies that cells bearing amplifications of VEGFA and TMEM100 are particularly sensitive to this treatment regime. CONCLUSIONS:Taken together, these results suggest that heterogeneity and subclonal architecture influence the response to targeted treatment in combination with chemotherapy, with possible implications for clinical decision-making and monitoring of treatment efficacy. TRIAL REGISTRATION:NCT00773695 . Registered 15 October 2008.
journal_name
Genome Medjournal_title
Genome medicineauthors
Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen Vdoi
10.1186/s13073-018-0601-ysubject
Has Abstractpub_date
2018-11-29 00:00:00pages
92issue
1issn
1756-994Xpii
10.1186/s13073-018-0601-yjournal_volume
10pub_type
杂志文章,多中心研究,随机对照试验相关文献
Genome Medicine文献大全abstract:BACKGROUND:Clinical laboratory (lab) tests are used in clinical practice to diagnose, treat, and monitor disease conditions. Test results are stored in electronic health records (EHRs), and a growing number of EHRs are linked to patient DNA, offering unprecedented opportunities to query relationships between genetic ri...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00820-8
更新日期:2021-01-13 00:00:00
abstract::The microbial residents of the human gut are a major factor in the development and lifelong maintenance of health. The gut microbiota differs to a large degree from person to person and has an important influence on health and disease due to its interaction with the human immune system. Its overall composition and mic...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/gm469
更新日期:2013-07-31 00:00:00
abstract:BACKGROUND:While clinical factors such as age, grade, stage, and histological subtype provide physicians with information about patient prognosis, genomic data can further improve these predictions. Previous studies have shown that germline variants in known cancer driver genes are predictive of patient outcome, but no...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-0718-7
更新日期:2020-02-17 00:00:00
abstract:BACKGROUND:One of the major challenges in obesity treatment is to explain the high variability in the individual's response to specific dietary and physical activity interventions. With this study, we tested the hypothesis that specific DNA methylation changes reflect individual responsiveness to lifestyle intervention...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00794-7
更新日期:2020-11-16 00:00:00
abstract::Accurate interpretation of gene testing is a key component in customizing patient therapy. Where confirming evidence for a gene variant is lacking, computational prediction may be employed. A standardized framework, however, does not yet exist for quantitative evaluation of disease association for uncertain or novel g...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm347
更新日期:2012-05-28 00:00:00
abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm338
更新日期:2012-04-30 00:00:00
abstract:BACKGROUND:Young age at portoenterostomy has been linked to improved outcome in biliary atresia, but pre-existing biological factors may influence the rate of disease progression. In this study, we aimed to determine whether molecular profiling of the liver identifies stages of disease at diagnosis. METHODS:We examine...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm154
更新日期:2010-05-13 00:00:00
abstract:BACKGROUND:Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approa...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0407-3
更新日期:2017-02-10 00:00:00
abstract::Immunoinformatics involves the application of computational methods to immunological problems. Prediction of B- and T-cell epitopes has long been the focus of immunoinformatics, given the potential translational implications, and many tools have been developed. With the advent of next-generation sequencing (NGS) metho...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-015-0245-0
更新日期:2015-11-20 00:00:00
abstract::Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies th...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm171
更新日期:2010-08-05 00:00:00
abstract:BACKGROUND:Glioblastoma multiforme, the most common type of primary brain tumor in adults, is driven by cells with neural stem (NS) cell characteristics. Using derivation methods developed for NS cells, it is possible to expand tumorigenic stem cells continuously in vitro. Although these glioblastoma-derived neural ste...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm377
更新日期:2012-10-09 00:00:00
abstract::Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tumor-specific T cell recognition. Recently, researchers and clinicians have leveraged next generation sequencing technologies to identify neoantigens and to create personalized immunotherapies for cancer treatment. To cr...
journal_title:Genome medicine
pub_type: 杂志文章,评审
doi:10.1186/s13073-019-0666-2
更新日期:2019-08-28 00:00:00
abstract:BACKGROUND:Allele-specific expression (ASE) is differential expression of each of the two chromosomal alleles of an autosomal gene. We assessed ASE patterns in the human left atrium (LA, n = 62) and paired samples from the left ventricle (LV, n = 76) before and after ischemia, and tested the utility of differential ASE...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-016-0381-1
更新日期:2016-12-06 00:00:00
abstract:BACKGROUND:Phenotypic changes during cancer progression are associated with alterations in gene expression, which can be exploited to build molecular signatures for tumor stage identification and prognosis. However, it is not yet known whether the relative abundance of transcript isoforms may be informative for clinica...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-016-0339-3
更新日期:2016-08-17 00:00:00
abstract::Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VHL), the mutation fr...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm180
更新日期:2010-09-03 00:00:00
abstract::To help overcome the bottlenecks that limit the development of diagnostic and therapeutic products, academic and industrial researchers, patient organizations and charities, and regulatory and funding institutions should redefine the basis for sharing the knowledge collected in large-scale clinical and experimental st...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm29
更新日期:2009-03-04 00:00:00
abstract::Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to define and study the aging of technological and social networks and ecosystems, which may generate novel concepts...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm90
更新日期:2009-09-28 00:00:00
abstract:BACKGROUND:Studies of cancer mutations have typically focused on identifying cancer driving mutations that confer growth advantage to cancer cells. However, cancer genomes accumulate a large number of passenger somatic mutations resulting from various endogenous and exogenous causes, including normal DNA damage and rep...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00745-2
更新日期:2020-05-29 00:00:00
abstract:BACKGROUND:Preterm birth confers a high risk of adverse long term health outcomes for survivors, yet the underlying molecular mechanisms are unclear. We hypothesized that effects of preterm birth can be mediated through measurable epigenomic changes throughout development. We therefore used a longitudinal birth cohort ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm500
更新日期:2013-10-18 00:00:00
abstract:BACKGROUND:Molecular diagnostics can resolve locus heterogeneity underlying clinical phenotypes that may otherwise be co-assigned as a specific syndrome based on shared clinical features, and can associate phenotypically diverse diseases to a single locus through allelic affinity. Here we describe an apparently novel s...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm415
更新日期:2013-02-05 00:00:00
abstract::Considerable time and effort has been spent in developing analysis and quality assessment methods to allow the use of microarrays in a clinical setting. As is the case for microarrays and other high-throughput technologies, data from new high-throughput sequencing technologies are subject to technological and biologic...
journal_title:Genome medicine
pub_type: 社论
doi:10.1186/gm208
更新日期:2010-12-10 00:00:00
abstract::There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller studies that are 'hypot...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm507
更新日期:2013-11-29 00:00:00
abstract::A report on the Keystone Symposium 'Complex Traits: Genomics and Computational approaches', Breckenridge, Colorado, USA, 20-25 February 2012. ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm328
更新日期:2012-03-30 00:00:00
abstract::The Human Gene Mutation Database (HGMD((R))) is a comprehensive core collection of germline mutations in nuclear genes that underlie or are associated with human inherited disease. Here, we summarize the history of the database and its current resources. By December 2008, the database contained over 85,000 different l...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm13
更新日期:2009-01-22 00:00:00
abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/gm547
更新日期:2014-04-28 00:00:00
abstract:BACKGROUND:Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and reproducibility to ensure patient safet...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-015-0202-y
更新日期:2015-07-25 00:00:00
abstract:BACKGROUND:Wnt signaling is an evolutionarily conserved developmental pathway that is frequently hyperactivated in cancer. While multiple protein-coding genes regulated by Wnt signaling are known, the functional lncRNAs regulated by Wnt signaling have not been systematically characterized. METHODS:We comprehensively m...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00788-5
更新日期:2020-10-22 00:00:00
abstract:BACKGROUND:Systemic sclerosis (SSc) is a genetically complex autoimmune disease mediated by the interplay between genetic and epigenetic factors in a multitude of immune cells, with CD4+ T lymphocytes as one of the principle drivers of pathogenesis. METHODS:DNA samples exacted from CD4+ T cells of 48 SSc patients and ...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-020-00779-6
更新日期:2020-09-25 00:00:00
abstract:BACKGROUND:Advanced age is associated with cognitive and physical decline and is a major risk factor for a multitude of disorders. There is also a gap in life expectancy between males and females. DNA methylation differences have been shown to be associated with both age and sex. Here, we investigate age-by-sex differe...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-019-0693-z
更新日期:2019-12-31 00:00:00
abstract:BACKGROUND:Profiles of DNA methylation of many tissues relevant in human disease have been obtained from microarrays and are publicly available. These can be used to generate maps of chromatin compartmentalization, demarcating open and closed chromatin across the genome. Additionally, large sets of genome-wide transcri...
journal_title:Genome medicine
pub_type: 杂志文章
doi:10.1186/s13073-017-0443-z
更新日期:2017-06-07 00:00:00